RxDoctor Payments Data

Nicole Benjamin

Physician Assistant · Jacksonville, FLNPI 1184345647

Payments from drug & device makers

$8,562in general payments, 2019–2025

Across 438 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$835
  • AstraZeneca$831
  • Otsuka America Pharmaceutical, Inc.$792
  • Novo Nordisk$553
  • Lilly USA, LLC$516
  • Corcept Therapeutics$489
  • plus $5K from 41 others

What the payments were for

  • Food & beverage$8,48299%
  • Education$801%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,562 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$37,014
Medicare patients
111
Services billed
1,119

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide51$52,855
EliquisApixaban37$52,646
MounjaroTirzepatide40$43,598
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$36,477
JardianceEmpagliflozin21$25,824
FarxigaDapagliflozin Propanediol22$24,426
VraylarCariprazine Hcl14$22,304
XareltoRivaroxaban16$18,200
Soliqua 100-33Insulin Glargine/Lixisenatide14$11,533
MyrbetriqMirabegron12$10,967
QuviviqDaridorexant Hcl12$6,043
Lidocaine30$5,630
SymbicortBudesonide/Formoterol Fumarate17$5,615
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$3,812
Albuterol Sulfate HfaAlbuterol Sulfate153$3,649

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$553$52,85551 claims
PfizerEliquis$80$52,64637 claims
Lilly USA, LLCMounjaro$516$43,59840 claims
GSKTrelegy Ellipta$391$36,47736 claims
AstraZenecaFarxiga, Symbicort$831$30,04139 claims
Boehringer IngelheimJardiance$393$25,82421 claims
AbbVieVraylar, Synthroid$835$23,47025 claims
Johnson & JohnsonXarelto$33$18,20016 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$84$11,53314 claims
Astellas Pharma US IncMyrbetriq$160$10,96712 claims
Idorsia Pharmaceuticals US IncQuviviq$61$6,04312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →